ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Xalkori 200 mg, Hartkapseln - 60 Kapsel(n)
62131001 PPPfizer AG
Xalkori 200 mg, Hartkapseln05.03.2012
  05.03.2012
Crizotinib (L01ED01) 
WHO-DDD 
07.16.10.60 Kapsel(n)
07.16.10. 
A  
Yes 
IPCI
3716.38Yes
    
10 %4059.25
  
7680621310011Synthetika
5176146 
Composition
crizotinibum 200 mg, silica colloidalis anhydrica, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum A corresp. natrium 0.84 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, kalii hydroxidum, E 172 (nigrum), pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Crizotinibum200 mg
BAG: Active AgentDose
Crizotinibum200 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
(Rubrum)  
Ammoniae Solutio30  
Calcium Hydrogen Phosphate  
Carboxymethylamylum Natricum A  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Per Centum  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 04.06.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home